New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.

Unaided awareness of EMD Serono's Mavenclad (cladribine tablets) and Novartis' siponimod increased compared to previous quarters, but neurologists appear split on how, or if, they will incorporate the newest agents into their multiple sclerosis armamentarium, according to a new report from Spherix Global Insights

In 2010, Stonhard completed work in Genentech's ECP-1 Bacterial Manufacturing Facility, which was recently recognized with the 2010 Facility of the Year Award.